Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration

Purpose To identify baseline characteristics predictive of visual acuity (VA) outcomes at month 12 (M12) and treatment frequency in the first 12 months of the phase III HARBOR study. Design Retrospective, exploratory analysis of multicenter randomized controlled trial data. Methods setting : Randomi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of ophthalmology 2015-11, Vol.160 (5), p.1014-1023.e2
Hauptverfasser:	Regillo, Carl D, Busbee, Brandon G, Ho, Allen C, Ding, Beiying, Haskova, Zdenka
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Biomarkers Diabetic retinopathy Double-Blind Method FDA approval Female Follow-Up Studies Health Insurance Portability & Accountability Act 1996-US Humans Intravitreal Injections Macular degeneration Male Methods Middle Aged Occult sciences Ophthalmology Patients Photodynamic therapy Ranibizumab - administration & dosage Retina Retrospective Studies Time Factors Tomography, Optical Coherence Treatment Outcome Vascular endothelial growth factor Visual Acuity Wet Macular Degeneration - drug therapy Wet Macular Degeneration - pathology Wet Macular Degeneration - physiopathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!